| Literature DB >> 27471182 |
Jochen K Lennerz1, Heather M McLaughlin2, Jason M Baron3, David Rasmussen3, Meini Sumbada Shin2, Nancy Berners-Lee4, Julie Miller Batten3, Kathryn J Swoboda5, Manish K Gala6, Harland S Winter7, Jeremy D Schmahmann8, David A Sweetser9, Marianne Boswell3, Maciej Pacula3, Albrecht Stenzinger10, Long P Le3, William Hynes3, Heidi L Rehm2, Anne Klibanski11, Stephen W Black-Schaffer3, Jeffrey A Golden12, David N Louis3, Scott T Weiss2, A John Iafrate3.
Abstract
Next-generation sequencing has evolved technically and economically into the method of choice for interrogating the genome in cancer and inherited disorders. The introduction of procedural code sets for whole-exome and genome sequencing is a milestone toward financially sustainable clinical implementation; however, achieving reimbursement is currently a major challenge. As part of a prospective quality-improvement initiative to implement the new code sets, we adopted Agile, a development methodology originally devised in software development. We implemented eight functionally distinct modules (request review, cost estimation, preauthorization, accessioning, prebilling, testing, reporting, and reimbursement consultation) and obtained feedback via an anonymous survey. We managed 50 clinical requests (January to June 2015). The fraction of pursued-to-requested cases (n = 15/50; utilization management fraction, 0.3) aimed for a high rate of preauthorizations. In 13 of 15 patients the insurance plan required preauthorization, which we obtained in 70% and ultimately achieved reimbursement in 50%. Interoperability enabled assessment of 12 different combinations of modules that underline the importance of an adaptive workflow and policy tailoring to achieve higher yields of reimbursement. The survey confirmed a positive attitude toward self-organizing teams. We acknowledge the individuals and their interactions and termed the infrastructure: human pipeline. Nontechnical barriers currently are limiting the scope and availability of clinical genomic sequencing. The presented human pipeline is one approach toward long-term financial sustainability of clinical genomics.Entities:
Mesh:
Year: 2016 PMID: 27471182 PMCID: PMC5397703 DOI: 10.1016/j.jmoldx.2016.04.003
Source DB: PubMed Journal: J Mol Diagn ISSN: 1525-1578 Impact factor: 5.568